![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 8
2022
Kraus, Fabian B. T.; Topalov, Nicole E.; Deuster, E.; Hysenaj, I.; Mayr, D.; Chelariu-Raicu, A.; Beyer, S.; Kolben, T.; Burges, A.; Mahner, S.; Trillsch, F.; Jeschke, U. und Czogalla, B.
(2022):
Expression pattern and prognostic potential of histamine receptors in epithelial ovarian cancer.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 6: S. 2501-2511
[PDF, 1MB]
Bossart, M.; Plett, H.; Kraemer, B.; Braicu, E.; Czogalla, B.; Klar, M.; Singer, S.; Mayr, D.; Staebler, A.; du Bois, A.; Kommoss, S.; Link, T.; Burges, A.; Heitz, F.; Grube, M.; Trillsch, F.; Harter, P.; Wimberger, P.; Buderath, P. und Hasenburg, A.
(2022):
Depression and anxiety in women with malignant ovarian germ cell (MOGCT) and sex cord stromal tumors (SCST): an analysis of the AGO-CORSETT database.
In: Archives of Gynecology and Obstetrics, Bd. 307, Nr. 4: S. 1155-1162
2016
Woelber, L.; Haeringer, N.; Eulenburg, C.; Donata, G.; Trillsch, F.; Burandt, E.; Schmalfeldt, B.; Mahner, S.; Mueller, V. und Prieske, K.
(2016):
Patterns of distant metastases in vulvar cancer.
In: International Journal of Gynecological Cancer, Bd. 26: S. 1164
Du Bois, A.; Trillsch, F.; Mahner, S.; Heitz, F. und Harter, P.
(2016):
Management of borderline ovarian tumors.
In: Annals of Oncology, Bd. 27: S. 20-22
Mahner, S.; Trillsch, F.; Chi, D.; Harter, P.; Pfisterer, J.; Hilpert, F.; Burges, A.; Weissenbacher, T. und Du Bois, A.
(2016):
Neoadjuvant chemotherapy in ovarian cancer revisited.
In: Annals of Oncology, Bd. 27: S. 30-32
Trillsch, F.; Mahner, S.; Hilpert, F.; Davies, L.; García-Martínez, E.; Kristensen, G.; Savarese, A.; Vuylsteke, P.; Los, M.; Zagouri, F.; Gladieff, L.; Sehouli, J.; Lee, C. Khoon; Gebski, V. und Pujade-Lauraine, E.
(2016):
Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial.
In: Annals of Oncology, Bd. 27, Nr. 9: S. 1733-1739
Trillsch, F.; Mahner, S.; Hilpert, F.; Davis, L.; Garcia, E.; Kristensen, G.; Savarese, A.; Vuylsteke, P.; Loos, M.; Zagouri, F.; Gladieff, L.; Sehouli, J.; Lee, C. K.; Gebski, V. und Pujade-Lauraine, E.
(2016):
Prognostic and predictive values of primary vs secondary platinum resistance for bevacizumab treatment in platinum-resistant ovarian cancer in the AURELIA trial.
In: Oncology Research and Treatment, Bd. 39: S. 93
Woelber, L.; Eulenburg, C.; Grimm, D.; Trillsch, F.; Bohlmann, I.; Burandt, E.; Dieckmann, J.; Klutmann, S.; Schmalfeldt, B.; Mahner, S. und Prieske, K.
(2016):
The risk of contralateral non-sentinel metastasis in patients with primary vulvar cancer and unilaterally positive sentinel node.
In: Oncology Research and Treatment, Bd. 39: S. 95